Literature DB >> 21748908

Unaltered blood coagulation and platelet function in healthy subjects exposed to acute hypoxia.

Matti Mäntysaari1, Lotta Joutsi-Korhonen, Martti A Siimes, Simo Siitonen, Kai Parkkola, Marja Lemponen, Riitta Lassila.   

Abstract

INTRODUCTION: Acute hypoxia has been suspected to cause blood coagulation and platelet activation. Our aim was to study blood coagulation and platelet function during a short hypoxic exposure.
METHODS: Healthy nonsmoking men (N = 10) inhaled a normobaric hypoxic gas mixture containing 8% of oxygen (92% nitrogen) for 7 min via a face mask. Venous blood was collected 5 min before and during the 5 to 7 min of hypoxia exposure (i.e., pretest and hypoxia samples, respectively) while monitoring arterial oxygen saturation (SaO2) with pulse oximetry. Blood sampling was completed in 2 min and the face mask was removed. Venous epinephrine and norepinephrine, complete blood counts, and a panel of coagulation markers were analyzed. Platelet aggregation induced by ristocetin, adenosine diphosphate (ADP), arachidonic acid, and thrombin receptor activating peptide was studied with Multiplate and shear force-dependent functions with PFA-100R (collagen/epinephrine and collagen/ADP cartridges), both assays in whole blood.
RESULTS: During hypoxia, SaO2 declined from 98 to 58% (ranges 97-99% vs. 42-85%), while heart rate increased from 69/min to 94/min (SD 11 vs. SD 13). Venous epinephrine and norepinephrine levels also increased. This short hypoxia induced minor but uniform increases in red cells, reticulocytes, and leukocytes and decreases in platelet counts. Plateletfunctions and prothrombin time, APTT, thrombin time, D-dimer, fibrinogen levels or von Willebrand factor (VWF), antithrombin, factor V (FV) or FVIII activities did not change. DISCUSSION: Profound acute hypoxia failed to affect blood coagulation or platelet functions in healthy individuals.

Entities:  

Mesh:

Year:  2011        PMID: 21748908     DOI: 10.3357/asem.3012.2011

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  6 in total

1.  Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans.

Authors:  Matthijs Kox; Lucas T van Eijk; Jelle Zwaag; Joanne van den Wildenberg; Fred C G J Sweep; Johannes G van der Hoeven; Peter Pickkers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

2.  Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation.

Authors:  Klytaimnistra Kiouptsi; Stepan Gambaryan; Elena Walter; Ulrich Walter; Kerstin Jurk; Christoph Reinhardt
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

3.  The Effects of Cold Exposure Training and a Breathing Exercise on the Inflammatory Response in Humans: A Pilot Study.

Authors:  Jelle Zwaag; Rick Naaktgeboren; Antonius E van Herwaarden; Peter Pickkers; Matthijs Kox
Journal:  Psychosom Med       Date:  2022-02-23       Impact factor: 4.312

4.  Suppressive effects of anthrax lethal toxin on megakaryopoiesis.

Authors:  Po-Kong Chen; Hsin-Hou Chang; Guan-Ling Lin; Tsung-Pao Wang; Yi-Ling Lai; Ting-Kai Lin; Ming-Chun Hsieh; Jyh-Hwa Kau; Hsin-Hsien Huang; Hui-Ling Hsu; Chi-Yuan Liao; Der-Shan Sun
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

5.  The Effects of Mild Intermittent Hypoxia Exposure on the Abdominal Subcutaneous Adipose Tissue Proteome in Overweight and Obese Men: A First-in-Human Randomized, Single-Blind, and Cross-Over Study.

Authors:  Rens L J Van Meijel; Ping Wang; Freek Bouwman; Ellen E Blaak; Edwin C M Mariman; Gijs H Goossens
Journal:  Front Physiol       Date:  2022-01-04       Impact factor: 4.566

6.  Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial.

Authors:  Lisa Ayers; Anne-Christin Stoewhas; Berne Ferry; Tsogyal D Latshang; Christian M Lo Cascio; Ross Sadler; Katrin Stadelmann; Noemi Tesler; Reto Huber; Peter Achermann; Konrad E Bloch; Malcolm Kohler
Journal:  Eur J Appl Physiol       Date:  2014-02-11       Impact factor: 3.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.